PB1808: EPIGENETIC INHIBITOR SCREEN TO IDENTIFY THERAPEUTIC CANDIDATES FOR MNX1-OVEREXPRESSING AML

• Simge Kelekci,
• Anna Riedel,
• Dieter Weichenhan,
• Ashish Goyal,
• Katherine Kelly,
• Marion Baehr,
• Birgitta Michels,
• Cindy Koerner,
• Irene Orzella,
• James Dunford,
• Pavlo Lutsik,
• Stefan Wiemann,
• Udo Oppermann,
• Christoph Plass

Affiliations

Simge Kelekci

1 German Cancer Research Center, Division of Cancer Epigenomics, Heidelberg, Germany

Anna Riedel

1 German Cancer Research Center, Division of Cancer Epigenomics, Heidelberg, Germany

Dieter Weichenhan

1 German Cancer Research Center, Division of Cancer Epigenomics, Heidelberg, Germany

Ashish Goyal

1 German Cancer Research Center, Division of Cancer Epigenomics, Heidelberg, Germany

Katherine Kelly

1 German Cancer Research Center, Division of Cancer Epigenomics, Heidelberg, Germany

Marion Baehr

1 German Cancer Research Center, Division of Cancer Epigenomics, Heidelberg, Germany

Birgitta Michels

3 German Cancer Research Center, Division of Molecular Genome Analysis, Heidelberg, Germany

Cindy Koerner

3 German Cancer Research Center, Division of Molecular Genome Analysis, Heidelberg, Germany

Irene Orzella

4 Universita degli studi di Camerino, Department of Pharmacy, Camerino, Italy

James Dunford

5 University of Oxford, Nuffield Department of Orthopedics, Rheumatology and Musculoskeletal Sciences, Oxford, United Kingdom

Pavlo Lutsik

1 German Cancer Research Center, Division of Cancer Epigenomics, Heidelberg, Germany

Stefan Wiemann

3 German Cancer Research Center, Division of Molecular Genome Analysis, Heidelberg, Germany

Udo Oppermann

5 University of Oxford, Nuffield Department of Orthopedics, Rheumatology and Musculoskeletal Sciences, Oxford, United Kingdom

Christoph Plass

1 German Cancer Research Center, Division of Cancer Epigenomics, Heidelberg, Germany